A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome

Clinical Biochemistry

Volumn 48, Issue 16-17, 2015, Pages 1045-1047

  Dullaart, Robin P F ^a   Gruppen, Eke G ^a   Connelly, Margery A ^b   Lefrandt, Joop D ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

Bilirubin; Diabetes mellitus; Glycoproteins; High sensitivity C reactive protein; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL; ACUTE PHASE PROTEIN;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENZYME ACTIVITY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; INFLAMMATION; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

ACUTE-PHASE PROTEINS; BILIRUBIN; BIOMARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOPROTEINS; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84947028663     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.06.016     Document Type: Article

References (15)

1. Abraham N.G., Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 2005, 39:1-25.
2. Vitek L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front. Pharmacol. 2012, 3:55.
3. Kundur A.R., Singh I., Bulmer A.C. Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome?. Atherosclerosis 2015, 239:73-84.
4. Deetman P.E., Bakker S.J., Dullaart R.P.F. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc. Diabetol. 2013, 12:166. 10.1186/1475-2840-12-166.
5. Vitek L., Novotny L., Sperl M., Holaj R., Spacil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc. Dis. 2006, 21:408-414.
6. Dullaart R.P.F., Kappelle P.J., de Vries R. Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects. Clin. Chim. Acta 2012, 414:161-165.
7. Kunutsor S.K., Bakker S.J., Gansevoort R.T., Chowdhury R., Dullaart R.P.F. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler. Thromb. Vasc. Biol. 2015, 35:716-724.
8. Wallner M., Marculescu R., Doberer D., Wolzt M., Wagner O., Vitek L., et al. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin. Sci. (Lond.) 2013, 125:257-264.
9. Arnold J.N., Saldova R., Hamid U.M., Rudd P.M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8:3284-3293.
10. Gornik O., Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis. Markers 2008, 25:267-278.
11. Otvos J., Shalaurova I., Wolak-Dinsmore J., Connelly M.A., Mackey R.H., Stein J.H., et al. GlycA: a nuclear magnetic resonance biomarker of systemic inflammation. Clin. Chem. 2015, 61:714-723.
12. Akinkuolie A.O., Buring J.E., Ridker P.M., Mora S. A novel protein glycan biomarker and future cardiovascular disease events. J. Am. Heart Assoc. 2014, 3. (pii: e001221). 10.1161/JAHA.114.001221.
13. Kappelle P.J., Bijzet J., Hazenberg B.P., Dullaart R.P.F. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome. Arch. Med. Res. 2011, 42:219-225.
14. Mariño K., Bones J., Kattla J.J., Rudd P.M. A systematic approach to protein glycosylation analysis: a path through the maze. Nat. Chem. Biol. 2010, 6:713-723.
15. Jangi S., Otterbein L., Robson S. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Int. J. Biochem. Cell Biol. 2013, 45:2843-2851.